-
881
Novel role of microphthalmia-associated transcription factor in modulating the differentiation and immunosuppressive functions of myeloid-derived suppressor cells
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
882
Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3
Published 2021-03-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
883
Knockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic Fc-active TIGIT antibodies
Published 2023-12-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
884
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy
Published 2024-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
885
Cancer vaccines compensate for the insufficient induction of protective tumor-specific immunity of CD3 bispecific antibody therapy
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
886
Vinblastine resets tumor-associated macrophages toward M1 phenotype and promotes antitumor immune response
Published 2023-08-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
887
Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
888
Single-chain variable fragment affinity tuning can optimize anti-AML CAR-NK cell functionality
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
889
Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
890
Sex and outcomes of patients with microsatellite instability-high and BRAF V600E mutated metastatic colorectal cancer receiving immune checkpoint inhibitors
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
891
Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice
Published 2023-03-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
892
Tumor-infiltrating lymphocytes mediate complete and durable remission in a patient with NY-ESO-1 expressing prostate cancer
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
893
First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
894
Next-generation ctDNA-driven clinical trials in precision immuno-oncology
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
895
Combined PARP14 inhibition and PD-1 blockade promotes cytotoxic T cell quiescence and modulates macrophage polarization in relapsed melanoma
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
896
Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study
Published 2024-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
897
Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
898
SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
899
Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer
Published 2021-11-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
900
Effect of radiotherapy exposure on fruquintinib plus sintilimab treatment in refractory microsatellite stable metastatic colorectal cancer: a prospective observation study
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article